דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים: fortebiorx.com (FBRX)

The year-over-year percentage change in sales volume for LTM helps assess the management transparency of the micro-cap biotech Forte Biosciences, Inc. (FBRX). A stable patent portfolio of small molecules for skin creates an asset base, although fierce competition with pharma behemoths increases risks. The 0.00 metric confirms the current level of revenue dynamics, allowing analysts to track the operational speed of business expansion between quarterly reports.
Forte Biosciences (FBRX) - פילוחי מדדים ודוחות פיננסיים

This indicator measures revenue dynamics over a rolling twelve-month period, neutralizing seasonal factors to identify the true trajectory of business development. An analysis of year-over-year (TTM) revenue changes for Forte Biosciences, Inc. (FBRX) highlights the company's critical dependence on clinical trial outcomes, as the absence of commercial sales renders this metric highly volatile, signaling significant fundamental risks.